Cardiac Arrhythmia Monitoring Devices Market Cost Analysis, Strategy and Growth Factor Report 2019| Abbott Laboratories, Medtronic plc, G.E. Healthcare, BioTelemetry, Inc., Applied Cardiac Systems, Inc.

The global cardiac arrhythmia monitoring devices market was estimated at USD 5,200 million in 2019 and is expected to grow at 6.7% CAGR during the forecast period.

Cardiac Arrhythmia Monitoring Devices Market is predicted to expand rapidly altogether development areas over the forecast period between 2019 and 2026. Cardiac Arrhythmia Monitoring Devices Market report focuses on the main drivers and restraints for the key players and presents competition status with growth prospects. Cardiac Arrhythmia Monitoring Devices Market report is professional and in-depth research by experts on the present state of the Cardiac Arrhythmia Monitoring Devices Industry.

CVD is the leading cause of death worldwide, and nearly 30 million people suffer annually from a heart attack or stroke, as per the World Health Organization (WHO). Several risk factors such as family history, age, consumption of cigarettes, hypertension, high cholesterol, obesity, physical sedentariness, diabetes, unhealthy diets, and excessive alcohol consumption are numerous risk factors contributing to CVD.

As per the American Heart Association, nearly half the adults in the U.S.suffer from CVD, and by 2035, it is projected to occur in more than 130 million people. People with severe CVD are at greater risk of cardiac arrhythmias, such as tachycardia and bradycardia, and need to be continuously monitored to avert acute heart failure. It is possible to avoid most forms of CVDs by pre-monitoring and pre-diagnosis.

Likewise, with early diagnosis, irregularities in the functioning of the heart termed arrhythmias can be prevented. As a result, the market for CM & CRM products is rising as these devices help save patients at high risk of a heart attack. Thus, with the increasing prevalence of cardiac disorders, the market might witness good demand over the coming years.

Congenital heart disorders, coronary artery disease, elevated blood pressure, and other forms of cardiovascular diseases are typical causes of irregular heart rhythms (arrhythmias) or symptoms that may induce arrhythmias (CVD). Cardiovascular disease is the leading global cause of death, contributing to more than 17.6 million deaths per year in 2016, a figure that is projected to rise to more than 23.6 million by 2030, as reported by the American Heart Association 2019. Cardiac Arrhythmia Monitoring Devices marketing research report provides the most recent industry data and industry future trends, allowing you to spot the products and end users driving Revenue growth and profitability.

Grab a Free Sample PDF copy of the Cardiac Arrhythmia Monitoring Devices Market Report @ 
https://straitsresearch.com/report/cardiac-arrhythmia-monitoring-devices-market/request-sample

The Major Players Covered in this Report:
Abbott Laboratories
Medtronic plc
G.E. Healthcare
BioTelemetry, Inc.
Applied Cardiac Systems, Inc.
Alive Cor, Inc.
Nihon Kohden Corporation
Fukuda Denshi Co. Ltd.
Spacelabs Healthcare

By Devices
Holter Device
Event Recorder
Mobile Cardiac Telemetry Monitors
Implantable Cardiac Monitors
Electrocardiogram (ECG) Monitors
Others

By Application
Bradycardia
Tachycardia
Atrial Fibrillation (A.F.)
Ventricular Fibrillation (V.F.)
Premature Ventricular Contractions (PVC)
Others

By End-User
Hospitals & Clinics
Diagnostic Centers
Ambulatory Surgery Centers (ASC)
Homecare Settings
Others

Growing Domestic Demand and Expanding Pharmaceutical Sector to Drive the Demand for Cardiac Arrhythmia Monitoring Devices in the APAC Region
Asia-Pacific region is anticipated to hold the largest market share in the global Cardiac Arrhythmia Monitoring Devices market during the forecast period 2019-2029. The growth in this region can be attributed to the presence of emerging economies like India, China, Japan, Vietnam, and Indonesia, which account for the largest share in this region. India is one of the largest producers of Cardiac Arrhythmia Monitoring Devices and a major exporter of the product to various countries across the globe. India accounts for around 80% of the world’s exports of Cardiac Arrhythmia Monitoring Devices. The favorable climatic conditions and growth of agricultural inputs and allied services like cold storage and warehousing in India are prompting higher production.

View this report with a detailed description and TOC @ https://straitsresearch.com/report/cardiac-arrhythmia-monitoring-devices-market/toc

Global Cardiac Arrhythmia Monitoring Devices to Witness Rapid Growth in the North American Market:-
The rising prevalence of CVD is a crucial factor responsible for market growth. According to the American Heart Association (AHA), around 8, 36,546 people die annually from CVD in the U.S, and nearly 92.1 million Americans suffer from some cardiovascular disease. According to the CDC's statistics, around 2.7-6.1 million individuals in the U.S. have Atrial Fibrillation.

The rising penetration of innovative cardiovascular technologies and sophisticated healthcare facilities is another critical factor responsible for regional market dominance. Mobile Cardiac Outpatient Telemetry (MCOT) is experiencing a high rate of adoption in the U.S. With the need for more affordable options, G.E. Healthcare has introduced the portable MAC 800 ECG.

In May 2019, AliveCorreceived FDA approval from the U.S. for KardiaMobile 6L, the 1st6-lead personal ECG device to capture full information using a form factor. This approach also helped broaden the product range of the company's wireless devices business. Abbott obtained US FDA approval for the Confirm Rx Insertable Cardiac Monitor in October 2017 (ICM). Therefore, this region's market is expected to see fast growth over the projected period, taking into account all the factors mentioned above.

ECG Monitor Segment in Asia-Pacific Market Is Projected to Be in a Dominant Position over Forecast Years:-
The escalating burden of cardiovascular diseases primarily drives the APAC cardiac arrhythmia monitoring market.  The rate of diagnosis of cardiovascular diseases increases over time due to the rising burden of cardiac diseases and the need to control mortality rate by early diagnosis and treatment for CVD with cardiac monitoring devices. According to the WHO, smoking causes around 1 million cardiovascular deaths in the Asia-Pacific region annually. The Heart Foundation states that CVD is a major cause of death in Australia, with 43,477 CVD-related deaths in 2017. The need for monitoring heart diseases ultimately increases the use of these devices.

Moreover, as the number of geriatric populations who are more prone to cardiovascular diseases is expected to increase,it ultimately surges the market's growth in the coming years. For instance, Japan has the world's fastest aging population. According to the World Ageing 2019 report, the population aged above 65 was 35.524 million in 2019 and is projected to reach 37.278 million by 2030.

The development of commercially advanced devices, with enabled Bluetooth sensor technology and mobile app technology, is expected to drive the popularity of ECG Monitors in this region. For instance, in 2018, Qardio, Inc., received approval from Australia's Therapeutic Goods Administration (TGA) for its revolutionary ECG monitorQardioCore. Furthermore, technological advancements and product innovations in the development of ECG devices are likely to propel the market growth.

The rising incidence of heart diseases in Asia-Pacific also influences healthcare service providers to implement advanced telehealth services. Hence, the increasing usage of telecardiology is expected to drive the market studied in the future.

View Full Report @ https://straitsresearch.com/report/cardiac-arrhythmia-monitoring-devices-market/

The report covers exhaustive analysis on:
Overview of the parent market
Global Cardiac Arrhythmia Monitoring Devices Market Segments, Dynamics, Market Size, Share, Price, Volume, and Cost
Historical, current and projected market size in terms of volume and value
Global Cardiac Arrhythmia Monitoring Devices Market Forecast 2019 to 2026
Supply & Demand Value Chain
Global Cardiac Arrhythmia Monitoring Devices Market dynamics, including the current trends/drivers/threats/restraints/challenges
Potential and niche segments/regions exhibiting promising growth
Market landscape, competition, and leading companies involved
Strategies of leading companies and product offerings
Technological advancements

Key questions answered in this report:
What will be the market size by the end of the forecast period?
What are the factors driving the growth of the market?
What are the trends and developments that are likely to drive the growth of the market?
Who are the key players operating in the market?
What are the challenges, threats, and opportunities faced by the leading players?
What are the strengths and weaknesses of the key players of the market?

Buy Full Report with Detail Analysis with COVID-19 Impact – https://straitsresearch.com/buy-now/cardiac-arrhythmia-monitoring-devices-market/global/

Would you like to discuss Cardiac Arrhythmia Monitoring Devices Market challenges with the experts at Straits Research?

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enable us to determine greater insights by eliminating the research costs.

This release was published on openPR.